MAM
IBBQ icon

MMA Asset Management’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

MMA Asset Management’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,093
Closed -$50.9K – 234
2025
Q3 		$50.9K Buy
+2,093
New +$48.2K 0.02% 208

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

MMA Asset Management's IBBQ Position: Q4 2025 in Review

MMA Asset Management sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q4 2025, closing a stake of 2,093 shares — an estimated $50.9K sold.

MMA Asset Management first reported a position in IBBQ in Q3 2025 and held it in 1 quarter. The position peaked at $50.9K in Q3 2025. 31 funds tracked by Wall St. Rank hold IBBQ as of Q4 2025.

  • MMA Asset Management reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • MMA Asset Management sold 2,093 Invesco NASDAQ Biotechnology ETF shares in Q4 2025, an estimated $50.9K.
  • MMA Asset Management first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2025 and held it in 1 quarter.
  • MMA Asset Management's Invesco NASDAQ Biotechnology ETF position peaked at $50.9K in Q3 2025.
  • 31 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q4 2025.

Based on MMA Asset Management's 13F filing for Q4 2025, filed 3 Feb 2026.